The SLC39A4 gene helps your intestine absorb zinc from food, which your body needs for skin health, growth, immune function, and wound healing. When this gene does not work properly, your body may not take in enough zinc, leading to a rare inherited condition called acrodermatitis enteropathica. This gene plays an important role in keeping zinc levels steady, and low levels can cause rash, diarrhea, hair loss, and poor growth. Many people do well with ongoing zinc treatment.
What is a gene?
Genes are stretches of DNA that give your cells instructions they can use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do much of the work. Others mainly control when certain processes happen, where they occur, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
SLC39A4Gene function
What if the gene works
The SLC39A4 gene helps the small intestine absorb zinc from food. This supports growth, skin healing, immunity, and many enzymes that keep cells working normally.
Risk
What if the gene does not work
When the SLC39A4 gene does not work properly, the body may absorb too little zinc, causing acrodermatitis enteropathica with rash, diarrhea, hair loss, and poor growth. Milder or more severe variants can influence symptom onset and severity.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the SLC39A4 gene makes oral zinc replacement the key treatment, commonly with zinc sulfate, gluconate, or acetate. Care is usually long term, often lifelong, with the zinc dose adjusted to symptoms and blood zinc and copper levels. Other medicines do not substitute for zinc in this setting.
Conditions associated with SLC39A4
Gene function
What if the gene works
Zinc from food helps your body with everyday tasks, from tissue renewal to routine cell work. The SLC39A4 gene gives cells instructions for a protein that brings zinc into the body, especially through the small intestine. This steady zinc supply supports many enzymes and other proteins that need zinc to do their jobs.
The SLC39A4 gene helps move zinc from food into the cells lining the small intestine. Its protein acts like a gateway at the cell surface, bringing this essential mineral inside.
This is a key part of how the SLC39A4 gene helps absorb zinc from food. By increasing zinc uptake when supplies are lower, it helps keep the body's zinc levels in a healthy range.
Many proteins need zinc to hold the right shape and carry out routine tasks. By supplying zinc to cells, the SLC39A4 gene supports enzyme activity, cell growth, and tissue maintenance.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have a noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC39A4 gene can alter the ZIP4 protein’s shape, stability, or movement to the cell surface, which often reduces zinc uptake by intestinal cells. SLC39A4 gene variants that affect zinc absorption range from milder changes, which may leave some transport activity, to more severe variants that sharply reduce or stop it. In people with acrodermatitis enteropathica, this functional range can influence how early features appear and how strongly they show up.
How variants are linked to conditions
Pathogenic variants in the SLC39A4 gene cause acrodermatitis enteropathica, a rare inherited condition that often begins in infancy with skin rash, diarrhea, and poor growth. In clinical practice, the SLC39A4 gene is most strongly linked to acrodermatitis enteropathica, and finding disease-causing variants in both copies of the gene can confirm the diagnosis. Some people are identified later because symptoms can vary from person to person.
A variant is not necessarily a diagnosis
Variants in DNA are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, having a variant linked to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC39A4, the main risk is having disease-causing changes in both copies of the gene, so lifestyle does not meaningfully remove that inherited risk. In people living with this condition, symptoms often start or get worse after weaning from breast milk and during times of low zinc intake, poor absorption, fast growth, illness, or pregnancy.
Inheritance of SLC39A4 variants
SLC39A4-related acrodermatitis enteropathica is inherited in an autosomal recessive pattern. This means a child usually inherits one SLC39A4 gene variant from each parent, and parents who carry one variant typically do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variants. Because the SLC39A4 gene is on an autosome, this inheritance pattern is the same for boys and girls.
What does my SLC39A4 result mean for my family?
Changes in the SLC39A4 gene are linked to a condition that usually runs in families in a recessive pattern. For family members, this often means parents can be healthy carriers, and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change is present, especially if there is a family history of low zinc levels, ongoing diarrhea, or a rash that keeps coming back.
Genetic information
Genetic testing
How you find out about variants
Genetic testing can look for variants in the SLC39A4 gene using a blood or saliva sample. This kind of SLC39A4 genetic testing reads the gene's DNA code to check for changes that may confirm a diagnosis or show whether someone is a carrier.
When should I consider getting a genetic test?
Genetic testing for the SLC39A4 gene can be worth considering if someone has signs of an inherited problem absorbing zinc, such as an ongoing rash, diarrhea, hair loss, poor growth, or repeated low zinc levels, especially in infancy. It can also help when this condition is known or suspected in the family.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but the amount they reveal varies with the condition and the kind of variant that is found. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered together with the rest of a person’s care. In other situations, a genetic result can give a more definite answer. For areas like medication response, these results can also help explain individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems less effective for another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, which can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics looks at how differences in genes can affect the way someone responds to medications. It examines links between genes and drugs to better understand why the same treatment may work differently from one person to the next. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. If you want to learn more about this topic, you can read further in the LearnHub.
Drugs influenced by the SLC39A4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices or drug response. If you have concerns about side effects, zinc or other supplements, or how a treatment fits with your overall health, talk with your doctor or pharmacist.
History
Doctors first described the inherited condition now linked to the SLC39A4 gene in the mid 20th century, after noticing a distinctive pattern of skin changes, diarrhea, and poor growth in some infants. In the 1970s, a major breakthrough came when researchers showed that zinc treatment could reverse these symptoms, helping shift attention toward the body’s handling of zinc. Building on this early work, scientists uncovered more about the gene. In 2002, variants in the SLC39A4 gene were identified as the cause of acrodermatitis enteropathica, connecting earlier clinical observations with a specific inherited change. This discovery gave families a clearer explanation and helped genetic diagnosis become more precise.